Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, 40126 Bologna, Italy.
Clinical Nutrition and Metabolism Unit, IRCCS AOUBO, Via Albertoni, 15, 40138 Bologna, Italy.
Nutrients. 2024 Oct 2;16(19):3348. doi: 10.3390/nu16193348.
BACKGROUND/OBJECTIVES: Pegvaliase, a subcutaneous therapy to treat phenylketonuria (PKU), has allowed these patients to maintain adequate phenylalanine (Phe) blood values without following a Phe-controlled diet; this brings up the challenge of promoting healthy eating while moving away from prescription diets. In our center, every patient treated with Pegvaliase undergoes routine nutritional counseling aimed at promoting adherence to the Mediterranean diet (MedDiet) during regular inpatient visits. This study aims to assess adherence to MedDiet and the adequacy of the diets of patients treated with Pegvaliase regarding micro- and macronutrients.
Seven patients on chronic therapy with Pegvaliase underwent a dietetic evaluation to assess the composition of their diets in terms of micro- and macronutrients; they were also administered the Mediterranean Diet Score (MDS) questionnaire. Subcategories from MDS were extracted to evaluate the consumption of foods typically included (vegetables, olive oil, etc.) and typically excluded (red meat, etc.) in the MedDiet. To assess the adequacy of the diet, nutrient and energy levels were compared with guidelines for the Italian population.
MedDiet adherence in our sample was comparable to the general population; in terms of macronutrients, good adherence to the recommendations was observed, with every one of them met except for excessive simple sugar consumption. Micronutrient dietary intake was inadequate for zinc, iron, selenium, folate, thiamine, and riboflavin.
While more work is necessary to help patients treated with Pegvaliase to progress toward healthy eating, our study suggests that nutritional counseling routinely performed during inpatient visits, typically twice a year, effectively promotes healthier eating habits than those observed in the general population.
背景/目的:培加酶是一种治疗苯丙酮尿症(PKU)的皮下治疗药物,它使这些患者能够在不遵循苯丙氨酸(Phe)控制饮食的情况下维持足够的 Phe 血值;这就提出了一个挑战,即如何在远离处方饮食的情况下促进健康饮食。在我们中心,每一位接受培加酶治疗的患者都会接受常规的营养咨询,旨在促进他们在定期住院期间坚持地中海饮食(MedDiet)。本研究旨在评估接受培加酶治疗的患者对 MedDiet 的依从性以及其饮食中微量和宏量营养素的充足性。
7 名接受慢性培加酶治疗的患者接受了饮食评估,以评估其饮食中微量和宏量营养素的组成;他们还接受了地中海饮食评分(MDS)问卷。从 MDS 中提取亚类,以评估通常包括(蔬菜、橄榄油等)和通常排除(红肉等)在 MedDiet 中的食物的消费。为了评估饮食的充足性,将营养素和能量水平与意大利人口的指南进行了比较。
我们样本中的 MedDiet 依从性与一般人群相当;就宏量营养素而言,观察到对建议的良好依从性,除了过量的简单糖消耗外,其他所有营养素都得到了满足。微量营养素的饮食摄入不足,包括锌、铁、硒、叶酸、硫胺素和核黄素。
虽然还需要做更多的工作来帮助接受培加酶治疗的患者朝着健康饮食的方向发展,但我们的研究表明,在住院期间通常每年两次进行的常规营养咨询有效地促进了更健康的饮食习惯,这比一般人群中观察到的饮食习惯更好。